Terms: = Bone cancer AND TRA
14 results:
1. Risk Factors for Treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
[No Abstract] [Full Text] [Related]
2. A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells.
Naeem A; Gupta N; Naeem U; Khan MJ; Elrayess MA; Cui W; Albanese C
Cell Cycle; 2022 Aug; 21(15):1543-1556. PubMed ID: 35412950
[TBL] [Abstract] [Full Text] [Related]
3. Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Palandri F; Rossi E; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Carrai V; Barcellini W; Patriarca A; Rivolti E; Consoli U; Cantoni S; Oliva EN; Chiurazzi F; Caocci G; Giuffrida G; Borchiellini A; Auteri G; Baldacci E; Carli G; Nicolosi D; Sutto E; Carpenedo M; Cavo M; Mazzucconi MG; Zaja F; De Stefano V; Rodeghiero F; Vianelli N
Blood; 2021 Aug; 138(7):571-583. PubMed ID: 33889952
[TBL] [Abstract] [Full Text] [Related]
4. Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma.
Li L; Luo C; Song Z; Reyes-Vargas E; Clayton F; Huang J; Jensen P; Chen X
Nanomedicine; 2018 Feb; 14(2):581-593. PubMed ID: 29170110
[TBL] [Abstract] [Full Text] [Related]
5. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.
O'Brien CM; Chy HS; Zhou Q; Blumenfeld S; Lambshead JW; Liu X; Kie J; Capaldo BD; Chung TL; Adams TE; Phan T; Bentley JD; McKinstry WJ; Oliva K; McMurrick PJ; Wang YC; Rossello FJ; Lindeman GJ; Chen D; Jarde T; Clark AT; Abud HE; Visvader JE; Nefzger CM; Polo JM; Loring JF; Laslett AL
Stem Cells; 2017 Mar; 35(3):626-640. PubMed ID: 28009074
[TBL] [Abstract] [Full Text] [Related]
6. Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.
Kovjazin R; Horn G; Smorodinsky NI; Shapira MY; Carmon L
PLoS One; 2014; 9(1):e85400. PubMed ID: 24416403
[TBL] [Abstract] [Full Text] [Related]
7. [A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].
Fujita Y; Mizuta N; Sakaguchi K; Nakatsukasa K; Imai A; Umeda Y; Hamaoka A; Morita M; Shouji M; Goto M; Taguchi T
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1699-702. PubMed ID: 23152022
[TBL] [Abstract] [Full Text] [Related]
8. Effect of differentiating agents on interferon-gamma (INF-gamma) level in leukemic cells propagated ex-vivo.
El-Houseini ME; Amer IR; Hussein TD
J Egypt Natl Canc Inst; 2006 Dec; 18(4):283-91. PubMed ID: 18301452
[TBL] [Abstract] [Full Text] [Related]
9. [Recombinant human TSH use in differentiated thyroid cancer].
Graf H; Paz-Filho G
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):806-12. PubMed ID: 17891244
[TBL] [Abstract] [Full Text] [Related]
10. Retinoic acid--a player that rules the game of life and death in neutrophils.
Mehta K
Indian J Exp Biol; 2002 Aug; 40(8):874-81. PubMed ID: 12597015
[TBL] [Abstract] [Full Text] [Related]
11. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract] [Full Text] [Related]
12. In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.
Jiang SY; Shyu RY; Chen HY; Lee MM; Wu KL; Yeh MY
Oncology; 1996; 53(4):334-40. PubMed ID: 8692540
[TBL] [Abstract] [Full Text] [Related]
13. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
Damjanov I; Horvat B; Gibas Z
Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
[TBL] [Abstract] [Full Text] [Related]
14. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
Wiernik PH; Dutcher JP; Paietta E; Hittelman WN; Vyas R; Strack M; Castaigne S; Degos L; Gallagher RE
Leukemia; 1991 Jun; 5(6):504-9. PubMed ID: 2056773
[TBL] [Abstract] [Full Text] [Related]